Patents by Inventor Jonathan A. Tobert

Jonathan A. Tobert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of Treating Pathological Blushing
    Publication number: 20070299122
    Abstract: A method of treating pathological blushing is disclosed wherein the patient is administered a DP receptor antagonist. Compositions containing DP antagonists are also included.
    Type: Application
    Filed: November 7, 2005
    Publication date: December 27, 2007
    Inventors: Jonathan Tobert, Eseng Lai
  • Combination therapy for reducing the risks associated with cardiovascular disease
    Patent number: 6673831
    Abstract: The instant invention provides methods for preventing or reducing the risk of developing atherosclerosis, as well as for halting or slowing the progression of atherosclerotic disease once it has become clinically evident, comprising the administration of a therapeutically effective amount of an HMG-CoA RI in combination with folic acid or a pharmaceutically acceptable salt or ester thereof to a person who is at risk of developing atherosclerosis or who already has atherosclerotic disease.
    Type: Grant
    Filed: April 27, 1998
    Date of Patent: January 6, 2004
    Assignee: Merck & Co., Inc.
    Inventor: Jonathan A. Tobert
  • Coenzyme Q.sub.10 with HMG-CoA reductase inhibitors
    Patent number: 4929437
    Abstract: A pharmaceutical composition and method of counteracting HMG-CoA reductase inhibitor-associated elevated transaminase levels is disclosed. The method comprises the adjunct administration of an effective amount of a HMG-CoA reductase inhibitor and an effective amount of Coenzyme Q.sub.10.
    Type: Grant
    Filed: February 2, 1989
    Date of Patent: May 29, 1990
    Assignee: Merck & Co., Inc.
    Inventor: Jonathan A. Tobert
  • Indacrinone having enhanced uricosuric
    Patent number: 4510322
    Abstract: The uricosuric and diuretic properties of indacrinone, [6,7-dichloro-2,3-dihydro-2-methyl-1-oxo-2-phenyl-1H-inden-5-yl)oxy]acetic acid, are carefully balanced for maximum therapeutic benefit by manipulation of the proportion of (+) and (-) enantiomers in the final product within critical limits.
    Type: Grant
    Filed: February 3, 1983
    Date of Patent: April 9, 1985
    Assignee: Merck & Co., Inc.
    Inventors: Edward H. Blaine, Edward J. Cragoe, Jr., Ralph F. Hirschmann, John F. Nancarrow, deceased, by Elisabeth M. Nancarrow, executrix, Jonathan A. Tobert
  • Rapid acting combination of phenyl benzoic acid compounds and magnesium hydroxide
    Patent number: 4217340
    Abstract: A novel, rapid acting drug combination comprising a phenyl benzoic acid compound and magnesium hydroxide. The combination results in earlier, higher plasma levels of the analgesic, anti-inflammatory drug.
    Type: Grant
    Filed: March 21, 1979
    Date of Patent: August 12, 1980
    Assignee: Merck & Co., Inc.
    Inventor: Jonathan A. Tobert